Biotech · Private company
Promentis Pharmaceuticals, Inc.
Track this companyFree. Adds Promentis Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- SXC-2023Phase 2 · Impulse Control DisordersClinicalTrials.gov · fetched Nov 12, 2026
- SXC-2023Phase 2 · TrichotillomaniaClinicalTrials.gov · fetched Nov 12, 2026
- SXC-2023Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Restoring Cognitive Control (ReCon) in Acute Nicotine WithdrawalPHASE2 · COMPLETED · started Mar 4, 2019ClinicalTrials.gov NCT03887429 · fetched Nov 12, 2026
- A Study in Patients With TrichotillomaniaPHASE2 · COMPLETED · started Dec 19, 2018ClinicalTrials.gov NCT03797521 · fetched Nov 12, 2026
- Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of SXC-2023 in Healthy VolunteersPHASE1 · COMPLETED · started Sep 11, 2017ClinicalTrials.gov NCT03301298 · fetched Nov 12, 2026